Google News – FDA (biotech/pharma) External News
Life Sciences & Pharma Articles
Google News – Pharmaceuticals External News
ADARx Pharmaceuticals files for IPO to fund RNA therapies for serious diseases - Pluang
Google News – Pharmaceuticals External News
What Health Equity Champions Can Learn from Pharmaceutical Sales - MedCity News
Google News – Clinical Trials External News
Hybrid Decentralized Trial Design Helps VA Reach More Prostate Cancer Patients - U.S. Medicine
Google News – Biopharma External News
Acumen at Citi biopharma summit: bets on oligomers and brain delivery - Investing.com
Google News – Pharmaceuticals External News
Syndax Pharmaceuticals at Citigroup’s Biopharma Back to School Summit 2026: revuforj gains - Investing.com
Google News – Biotech Funding External News
Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs - Fierce Biotech
Google News – Pharmaceuticals External News
Cosette appoints Andrew Adams as VP, supply chain & sourcing - PharmaLive
Google News – Pharmaceuticals External News
ADARx Pharmaceuticals Seeks IPO On Strong Collaboration Deal With AbbVie (Pending:ADRX) - Seeking Alpha
Google News – FDA (biotech/pharma) External News
FDA expands Bayer lung cancer drug approval - statnews.com
Google News – Pharmaceuticals External News
Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs - BioSpace
Google News – Biopharma External News
Syndax Pharmaceuticals at Citigroup’s Biopharma Back to School Summit 2026: revuforj gains - Investing.com UK
Google News – Pharmaceuticals External News
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Google News – Pharmaceuticals External News
Retension Pharmaceuticals Appoints LeAnne Bloedon and Kevin Schutz as Clinical and Regulatory Leaders - citybiz
Google News – Oncology External News